Lung Cancer Screening Programs: a missed “window” to diagnose Obstructive Lung Disease. The NLST-ACRIN experience.

J. De Torres Tajes (Pamplona, Spain), J. Wisnivesky (New York, United States of America), D. Wilson (Pittsburgh , United States of America), C. Casanova (Tenerife, Spain), J. Marin (Zaragoza, Spain), V. Pinto Plata (Springfield, United States of America), M. Divo (Boston, United States of America), F. Polverino (Boston, United States of America), C. Cabrera (Las Palmas, Spain), J. Zulueta (Pamplona, Spain), B. Celli (Boston, United States of America), G. Bastarrika (Pamplona, Spain)

Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Session: Interdependence of COPD and comorbidities and the underlying mechanisms
Session type: Poster Discussion
Number: 3626
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. De Torres Tajes (Pamplona, Spain), J. Wisnivesky (New York, United States of America), D. Wilson (Pittsburgh , United States of America), C. Casanova (Tenerife, Spain), J. Marin (Zaragoza, Spain), V. Pinto Plata (Springfield, United States of America), M. Divo (Boston, United States of America), F. Polverino (Boston, United States of America), C. Cabrera (Las Palmas, Spain), J. Zulueta (Pamplona, Spain), B. Celli (Boston, United States of America), G. Bastarrika (Pamplona, Spain). Lung Cancer Screening Programs: a missed “window” to diagnose Obstructive Lung Disease. The NLST-ACRIN experience.. 3626

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019
Source: Eur Respir J, 53 (5) 1900164; 10.1183/13993003.00164-2019
Year: 2019



Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Source: Eur Respir J , 49 (3) 1700214; DOI: 10.1183/13993003.00214-2017
Year: 2017



Global Initiative for Chronic Obstructive Lung Disease (GOLD) 20th Anniversary: a brief history of time
Source: Eur Respir J, 50 (1) 1700671; 10.1183/13993003.00671-2017
Year: 2017



Tuberculosis associated Obstructive Lung disease- A Pilot Study
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018


Physical activity and symptom burden in COPD: The Canadian Cohort Obstructive Lung Disease (CanCOLD) study
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021


Impact of Pulmonary Hypertension on the Response to Pulmonary Rehabilitation in Obstructive Lung Disease
Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today
Year: 2019


The Burden of Asymptomatic Lung Cancer
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019

The Czech National Programme for Early De­tection of Chronic Obstructive Pulmonary Disease – interim results from the pivotal project.
Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research
Year: 2021



A Comparison of Pulmonary Rehabilitation Outcomes in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019

Study to Evaluate Satisfaction with the Inhalation Device Used by Patients with Asthma or Chronic Obstructive Pulmonary Disease and the Association with Adherence and Disease Control
Source: Virtual Congress 2020 – Novel insights into nursing interventions for managing patients with asthma and COPD
Year: 2020




Is Virtual Autonomous Physiotherapist Tele-rehabilitation Program in Chronic Obstructive Pulmonary Disease equal to Hospital-Based Pulmonary Rehabilitation?
Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine
Year: 2020


Effect of the Liverpool Healthy Lung Programme on Outcomes in Lung Cancer
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020


The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic.
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


The Minapild Study Project: New tools to identify causes and prevent Interstitial Lung Diseases
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019


Study Of Risk Factors For Arrhythmias Among Chronic Obstructive Pulmonary Disease Patients Having Ischaemic Heart Disease.
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019


European Respiratory Society Guideline on Long-term Home Non-Invasive Ventilation for Management of Chronic Obstructive Pulmonary Disease
Source: Guideline 2019
Year: 2019

Incident Depression in Patients with Chronic Obstructive Pulmonary Disease: a UK Population-based Study
Source: Virtual Congress 2020 – Novelties in pulmonary rehabilitation and chronic respiratory care
Year: 2020




Mechanisms of exercise intolerance in Global Initiative for Chronic Obstructive Lung Disease grade 1 COPD
Source: Eur Respir J 2014; 44: 1177-1187
Year: 2014



The European Respiratory Society spirometry tent: a unique form of screening for airway obstruction
Source: Eur Respir J 2012; 39: 1458-1467
Year: 2012



Case Series of COVID-19 Disease in Pediatric Chronic Lung Diseases
Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function
Year: 2021